A bioengineer shifts his career to explore how life experiences change the body

Shaped by a tumultuous childhood, Jason Buenrostro pivots from technology development to studying the biology of stress and adversity and finding new ways to boost resilience.

A man wearing a black fleece jacket over a blue dress shirt stands smiling in a laboratory.
Credit: Allison Colorado, Broad Communications
Broad core institute member and Harvard professor Jason Buenrostro leads a project focused on uncovering the molecular roots of resilience and response to stress.

In early October 2023, Broad Institute researcher Jason Buenrostro received some unexpected, career-changing news. He’d been awarded a prestigious “genius grant” from the MacArthur Foundation, in recognition of his work developing tools widely used by scientists to study how genes are turned on or off in individual cells. He had no idea he’d even been nominated. Getting that surprise phone call “was an emotionally charged moment,” said Buenrostro, who is a core institute member at the Broad and a professor of stem cell and regenerative biology at Harvard University.

The unrestricted, $800,000 award arrived at an opportune moment for Buenrostro. At the time, he’d been thinking a lot about his childhood and early memories of stressful times. As a child of immigrants from Mexico, he and his family lived in cousins’ living rooms or garages in the San Francisco Bay area before getting a permanent home of their own, and he witnessed the effects of poverty, addiction, and violence in his extended family and community. He and his siblings, however, benefited from a safe and loving home experience and, as they grew up, stayed out of trouble. They thrived in school and were the first in his family to graduate high school and attend college.

After becoming a celebrated scientist and Harvard professor, Buenrostro began to wonder how he’d achieved professional and personal success, while so many in his community and larger family struggled with poverty or addiction. He credits the unwavering support of his parents, who emphasized the importance of education, but Buenrostro wondered if that was the only factor. As a biologist, he naturally homed in on a scientific question: could there be a biological basis for physical and mental resilience in the face of adversity?

“Those of us who grew up poor or are first-generation, like I am, wonder why we made it and some of our friends and family members didn’t,” Buenrostro said. "I still have this deep desire to understand why it is that I got out and others didn't, especially acknowledging that I wasn't the smartest one."

This question stayed with him for years. Then he got news of the MacArthur award, which gave him not only the resources but a big confidence boost to make a bold choice. After spending the first decade of his career creating innovative research tools, Buenrostro in 2024 decided to shift his focus entirely to try to find answers to this question. He set a new goal to study the health impacts of life experiences like those that shaped his youth and, in partnership with a foundation that shares the same passion and desire to make headway on this problem, launched a pioneering effort to study it at scale and with scientific rigor. He committed to learning why some people who endure adversity and trauma go on to develop mental health, cardiovascular, or immune issues while others don’t, and what might be done to help those at risk.

But first, he’d need a crash course in brain circuits, stress hormones, and social sciences — and to overcome doubt from others, and himself.

A SCIENTIFIC TRAILBLAZER

For any young researcher, venturing into a new scientific field would be a risky move, but Buenrostro had ample experience charting his own course. At Santa Clara University, near his hometown of Redwood City, California, he was one of the school’s first undergraduates to pursue bioengineering through earning two degrees. He considered becoming a doctor but decided to embark on a career in research instead because he thought he could impact more people through new technologies or treatments developed through research.

During graduate school at Stanford University, he became the first member of a new researcher’s lab and soon demonstrated his skill and ingenuity as a tool-maker. He invented a creative method for analyzing the epigenome — the dynamic chemical marks on DNA that determine which genes are turned on and off, alter how cells work, and help the body respond to the environment. His method, ATAC-seq, was easier and cheaper to use than existing approaches and quickly became a standard tool in the field.

After Stanford, he moved to Boston in 2016 and, skipping the traditional postdoctoral position, became a junior fellow in the Harvard Society of Fellows and the first Broad Fellow at the Broad Institute where he led his own lab. Two years later, he joined the Harvard faculty, became an institute member of the Broad, and continued advancing his epigenomic tools by incorporating gene expression and spatial information, in addition to new computational methods.

FINDING PURPOSE

Buenrostro knew that his tools were enabling other scientists to make discoveries, yet he had a nagging sense that he should be doing more. He began to reflect on how he ended up at Harvard and Broad.

In his spare time, Buenrostro started intensely reading scientific papers on the effects of stress and learned that they can not only influence the decisions that shape a person’s life, but also damage the brain, the heart, and the immune system. He was especially intrigued to learn how war, famine, and disasters can shape health at a population level. “We know these things make imprints on communities, yet we don't understand where that's being biologically embedded,” he explained.

In reading the scientific literature, Buenrostro learned that it’s well known that stress can damage the body, and that stress hormones like adrenaline and cortisol interact with cells to change which genes are activated or deactivated by altering the epigenome. These changes can help the body adapt and be resilient, and they can also lead to negative health outcomes. But the details of how stress can change our DNA, cells, and tissues at the molecular level were still murky.

As he learned more, Buenrostro began envisioning a new application for the tools he developed: to measure and identify the key epigenetic impacts of life events. A better understanding of the molecular imprints of both positive and negative events could open the door to new preventive or therapeutic measures for people exposed to stress and trauma.

Yet he recognized his own knowledge gaps. Despite his success, Buenrostro admits to experiencing impostor syndrome and worrying about his colleagues’ perception of him. Some even warned that studying the biology of stress was “too crazy” and may ruin his career.

Buenrostro found encouragement in the support of his wife, Sara Prescott, an MIT neuroscience professor, who helped him learn more about neuroscience and urged him to pursue his passion. He also realized that, with his own personal history of adversity and his expertise in epigenetics tools and approaches, he might be particularly well placed to tackle these questions.

The MacArthur genius grant came at just the right time. “The award was like the nucleating moment where I could just trust that my ideas were good,” Buenrostro said. “In order to really advance our understanding of adversity, I would have to take some risks, and it gave me the confidence to take on a bold direction.”

A NEW PROJECT TAKES SHAPE

Buenrostro was contacted by the Treehouse Family Foundation, whose mission is to improve lifelong health and opportunity by preventing childhood adversity and reducing its effects. The foundation had an existing partnership with the Broad to explore the biological impact of trauma. Together, in 2022 they had launched the Broad Trauma Initiative, aimed at improving the health and well-being of trauma survivors and led by Karestan Koenen, an institute member at Broad and a professor of psychiatric epidemiology at Harvard T.H. Chan School of Public Health. Initiative leaders and members of the foundation soon recognized that understanding the molecular and cellular roots of trauma would require advanced epigenomics technology and expertise, so they invited Buenrostro to contribute to the effort. After meeting Buenrostro and learning more about the potential for revealing the impact of adversity using epigenetics, they suggested scaling up his efforts.

With a $50 million gift from the foundation, in 2025 Buenrostro launched the Biology of Adversity Project, which he now leads and which collaborates with the Broad Trauma Initiative. Based at the Broad, the effort is aimed at discovering how different life experiences get embedded in DNA, cells, and tissues.

To do this, he’s built an interdisciplinary team of scientists to investigate how stress and adversity affect different parts of the body and to conduct both molecular experiments in the lab and public health studies with human cohorts. The team is using approaches and technologies, including many developed at Broad, to do these studies at scale and look at the effects of stress and adversity across the whole body and in large numbers of people.

“Jason has an uncanny ability to find people who can nucleate around the ideas that he wants to push,” said Ravi Raju, a physician-scientist at Boston Children’s Hospital and one of the project’s lead researchers. “He embodies the passion, interest, drive, and curiosity that help our whole community move forward. He is a natural leader for this work.”

Project scientists are using model systems to measure the physiological effects of early-life stressors like social isolation and to assess the role of environmental enrichment in promoting resilience. They are also planning to look for durable epigenetic changes in the blood of people who have experienced adversity or trauma.

The team is already making progress on the genes, cells, and pathways involved. They’re also imagining a range of future possible interventions, such as dietary supplements that promote resiliency in at-risk communities or even gene therapy in cases of extreme trauma. In addition, they plan to identify measurable biomarkers that could quantify a person’s stress load and suggest steps to prevent illness. Just as molecular discoveries in cancer ushered in an era of precision therapies, a richer molecular understanding of stress and adversity could open the door to targeted approaches tailored to a person’s particular stress response.

For Buenrostro, the effort is not just a scientific problem, but reflects a deeply personal purpose. He’s optimistic that his work can one day help others overcome challenging circumstances.

“Fixing the damage of stress is something that keeps me up at night,” Buenrostro said. “We hope that the work we're doing improves our understanding of the shared human experience, and over time not only helps us better understand history, but also helps us build society for a better future.”